Torren Management’s CONMED CNMD Stock Holding History

Torren Management’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7	Closed	-$294	–	1092
2025 Q4	$294	Buy	+7	New	+$305	﹤0.01%	1391

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Torren Management's CNMD Position: Q1 2026 in Review

Torren Management sold out of CONMED (CNMD) in Q1 2026, closing a stake of 7 shares — an estimated $294 sold.

Torren Management first reported a position in CNMD in Q4 2025 and held it in 1 quarter. The position peaked at $294 in Q4 2025. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

Torren Management reported no remaining CONMED position as of Q1 2026 after selling out during the quarter.
Torren Management sold 7 CONMED shares in Q1 2026, an estimated $294.
Torren Management first reported a position in CONMED in Q4 2025 and held it in 1 quarter.
Torren Management's CONMED position peaked at $294 in Q4 2025.
236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Torren Management's 13F filing for Q1 2026, filed 30 Apr 2026.